IL4/IL13 are the central cytokines for type 2 inflammation in CRSwNP
Dupixent has rapid and sustained efficacy in CRSwNP with more than 50% reduction in mean nasal congestion.
MAT-BH-2201023/V1/FEB2023
This website is intended exclusively for healthcare professionals residing and/or working in Kuwait.
Dupixent has rapid and sustained efficacy in CRSwNP with more than 50% reduction in mean nasal congestion.
MAT-BH-2201023/V1/FEB2023
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.